|Legal Status||Class C|
Penalty for possession: Up to two years in prison and / or an unlimited fine.
Penalty for dealing: Up to 14 years in prison and / or an unlimited fine.
Zopiclone is a non-benzodiazepine sedative from the cyclopyrrolone family of drugs and is prescribed for the short-term management of severe Insomnia. It has a Sedative effect and is used to induce sleep for a short period of time. Some users may crush the tablets to inject but this is rare due to this method being very messy and dangerous. These medicines do not dissolve and if attempted to be injected is likely to cause damage to the veins, resulting in abscesses, Deep Vein Thrombosis (DVT), aneurysm, ulcers and varicose veins.
Dependence and Tolerance can develop with prologed use of Zopiclone.
|Short Term Effects||
Breathing & heart rate slow down, depressed respiratory function, high potential for abuse. Depressed mental activity and alertness, memory loss, loss of co-ordination, amnesia, paranoid behaviour and aggression. Overdose - this risk is increased if used with Alcohol, Opiates or other Sedative / Depressant substances, risk of Coma and death. Zopiclone may interact with a number of other medicines.
|Long Term Effects||
Dependence, risk of Coma and death. Research has shown that, even at prescribed doses, prolonged use of zopiclone may cause cancer that may affect the brain, lung, bowel, breast and bladder. Zopiclone can also have an adverse effect on the immune system increasing the risk of infections and colds, and is not recommended for people with liver or kidney disease, or women who are pregnant or breast-feeding.
Identified in Poland: • N-(2-(dimethylamino)cyclohexyl)-N-methylbenzo[d][1,3]dioxole-5-carboxamide (3,4-methylenedioxy-U-47700)a NPS Opioid
There have been recent deaths and hospitalisations relating to substance use at festivals.: Be aware that over the past few years there has been an increase in the dosage and purity of substances available, in particular MDMA ‘Ecstasy’ pills. Increased purity and dosage means an increase in potential for adverse effects. Pills and powders etc.. may not contain what is intended, different substances have different doses,effects, time of onset and duration. Where WEDINOS have tested pressed pills; the result relates only to the samples analysed and cannot be used to indicate the contents, profile or quality of a wider batch of the substance. This is always the case despite pills having the same logo, shape size and colour.